Charcot-marie-tooth disease and related genetic neuropathies

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 1, 2012, Pages 39-59

  Patzko, Agnes ^a   Shy, Michael E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CONNEXIN 32; GAP JUNCTION PROTEIN; PERIPHERAL MYELIN PROTEIN 22;

ACHILLES REFLEX; ADIE SYNDROME; ADULT; ALTITUDE DISEASE; ANKLE SPRAIN; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CAMPING; CASE REPORT; CHARCOT MARIE TOOTH TYPE 1A; CHILD; DYSARTHRIA; ELECTROPHYSIOLOGY; FALLING; FEMALE; GAIT; GAP JUNCTION; GENE MUTATION; GENETIC SCREENING; HEALTH CARE PERSONNEL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PERIPHERAL NEUROPATHY; PHENOTYPE; REVIEW; ROCKY MOUNTAIN SPOTTED FEVER; RUNNING; SCHOOL CHILD; SCHWANN CELL; WEAKNESS; X CHROMOSOME;

EID: 84856822560     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000411567.34085.da     Document Type: Review

References (21)

1. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103(2):259-280. (Pubitemid 10046623)
2. Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980;17(5): 329-336. (Pubitemid 10018613)
3. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18(6):619-625.
4. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968;18(6):603-618.
5. Shy ME, Jàni A, Krajewski KM, et al. Phenotypic clustering in MPZ mutations. Brain 2004;127(pt 2):371-384. (Pubitemid 38160322)
6. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72(2): 185-192.
7. Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69(1):22-33.
8. American Society of Human Genetics Board of Directors American College of Medical Genetics Board of Directors. Pointsto consider: ethical, legal, and psychosocial implications of genetictesting in children and adolescents. Am J Hum Genet 1995; 57(5):1233-1241.
9. Raeymaekers P, Timmerman V, Nelis E, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991; 1(2):93-97.
10. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66(2):219-232. (Pubitemid 121001361)
11. Shy ME, Siskind C, Swan ER, et al. CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007;68(11): 849-855. (Pubitemid 46568537)
12. Siskind CE, Murphy SM, Ovens R, et al. Phenotype expression in women with CMT1X. J Peripher Nerv Syst 2011;16(2): 102-107.
13. Taylor RA, Simon EM, Marks HG, Scherer SS. The CNS phenotype of X-linked Charcot-Marie-Tooth disease: morethan a peripheral problem. Neurology 2003;61(11): 1475-1478. (Pubitemid 37505564)
14. Feely SM, Laura M, Siskind CE, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011; 76(20):1690-1696.
15. Deng HX, Klein CJ, Yan J, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010; 42(2):165-169.
16. ZhangX, ChowCY, SahenkZ, et al. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 2008;131(pt8):1990-2001.
17. Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009;80(12): 1304-1314
18. d'Ydewalle C, Krishnan J, Timmerman V, Van Den Bosch L. The small heat-shock proteins: cellular functions and mutations causing neurodegeneration. In: O'ConnorV, Wyttenbach A, eds. Folding for the synapse. New York: Springer Science-Business Media LLC, 2011:49-76.
19. Pareyson D, Reilly MM, Schenone A, et al; CMT-TRIAAL; CMT-TRAUK groups. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011;10(4):320-328.
20. Burns J, Raymond J, Ouvrier R. Feasibility of foot and ankle strength training in childhood Charcot-Marie-Tooth disease. Neuromuscul Disord 2009;19(12):818-821.
21. Schenone A, Nobbio L, Monti Bragadin M, et al. Inherited neuropathies. Curr Treat Options Neurol 2011;13(2):160-179.